Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Lymphoscintigraphy and triangulated body marking for morbidity reduction during sentinel node biopsy in breast cancer

Identifieur interne : 001D07 ( Pmc/Curation ); précédent : 001D06; suivant : 001D08

Lymphoscintigraphy and triangulated body marking for morbidity reduction during sentinel node biopsy in breast cancer

Auteurs : Borys R. Krynyckyi [États-Unis] ; Michail K. Shafir [États-Unis] ; Suk Chul Kim [États-Unis] ; Dong Wook Kim [États-Unis] ; Arlene Travis [États-Unis] ; Renee M. Moadel [États-Unis] ; Chun K. Kim [États-Unis]

Source :

RBID : PMC:1308847

Abstract

Current trends in patient care include the desire for minimizing invasiveness of procedures and interventions. This aim is reflected in the increasing utilization of sentinel lymph node biopsy, which results in a lower level of morbidity in breast cancer staging, in comparison to extensive conventional axillary dissection. Optimized lymphoscintigraphy with triangulated body marking is a clinical option that can further reduce morbidity, more than when a hand held gamma probe alone is utilized. Unfortunately it is often either overlooked or not fully understood, and thus not utilized. This results in the unnecessary loss of an opportunity to further reduce morbidity.

Optimized lymphoscintigraphy and triangulated body marking provides a detailed 3 dimensional map of the number and location of the sentinel nodes, available before the first incision is made. The number, location, relevance based on time/sequence of appearance of the nodes, all can influence 1) where the incision is made, 2) how extensive the dissection is, and 3) how many nodes are removed. In addition, complex patterns can arise from injections. These include prominent lymphatic channels, pseudo-sentinel nodes, echelon and reverse echelon nodes and even contamination, which are much more difficult to access with the probe only. With the detailed information provided by optimized lymphoscintigraphy and triangulated body marking, the surgeon can approach the axilla in a more enlightened fashion, in contrast to when the less informed probe only method is used. This allows for better planning, resulting in the best cosmetic effect and less trauma to the tissues, further reducing morbidity while maintaining adequate sampling of the sentinel node(s).


Url:
DOI: 10.1186/1477-7800-2-25
PubMed: 16277655
PubMed Central: 1308847

Links toward previous steps (curation, corpus...)


Links to Exploration step

PMC:1308847

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Lymphoscintigraphy and triangulated body marking for morbidity reduction during sentinel node biopsy in breast cancer</title>
<author>
<name sortKey="Krynyckyi, Borys R" sort="Krynyckyi, Borys R" uniqKey="Krynyckyi B" first="Borys R" last="Krynyckyi">Borys R. Krynyckyi</name>
<affiliation wicri:level="1">
<nlm:aff id="I1">Department of Radiology, Division of Nuclear Medicine, The Mount Sinai School of Medicine, The Mount Sinai Hospital, New York, New York, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Radiology, Division of Nuclear Medicine, The Mount Sinai School of Medicine, The Mount Sinai Hospital, New York, New York</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Shafir, Michail K" sort="Shafir, Michail K" uniqKey="Shafir M" first="Michail K" last="Shafir">Michail K. Shafir</name>
<affiliation wicri:level="1">
<nlm:aff id="I2">Department of Surgery, The Mount Sinai School of Medicine, The Mount Sinai Hospital, New York, New York, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Surgery, The Mount Sinai School of Medicine, The Mount Sinai Hospital, New York, New York</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Kim, Suk Chul" sort="Kim, Suk Chul" uniqKey="Kim S" first="Suk Chul" last="Kim">Suk Chul Kim</name>
<affiliation wicri:level="1">
<nlm:aff id="I1">Department of Radiology, Division of Nuclear Medicine, The Mount Sinai School of Medicine, The Mount Sinai Hospital, New York, New York, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Radiology, Division of Nuclear Medicine, The Mount Sinai School of Medicine, The Mount Sinai Hospital, New York, New York</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Kim, Dong Wook" sort="Kim, Dong Wook" uniqKey="Kim D" first="Dong Wook" last="Kim">Dong Wook Kim</name>
<affiliation wicri:level="1">
<nlm:aff id="I1">Department of Radiology, Division of Nuclear Medicine, The Mount Sinai School of Medicine, The Mount Sinai Hospital, New York, New York, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Radiology, Division of Nuclear Medicine, The Mount Sinai School of Medicine, The Mount Sinai Hospital, New York, New York</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Travis, Arlene" sort="Travis, Arlene" uniqKey="Travis A" first="Arlene" last="Travis">Arlene Travis</name>
<affiliation wicri:level="1">
<nlm:aff id="I1">Department of Radiology, Division of Nuclear Medicine, The Mount Sinai School of Medicine, The Mount Sinai Hospital, New York, New York, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Radiology, Division of Nuclear Medicine, The Mount Sinai School of Medicine, The Mount Sinai Hospital, New York, New York</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Moadel, Renee M" sort="Moadel, Renee M" uniqKey="Moadel R" first="Renee M" last="Moadel">Renee M. Moadel</name>
<affiliation wicri:level="1">
<nlm:aff id="I3">Department of Nuclear Medicine, Albert Einstein College of Medicine of Yeshiva University, and the Montefiore Medical Center, Bronx, New York, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Nuclear Medicine, Albert Einstein College of Medicine of Yeshiva University, and the Montefiore Medical Center, Bronx, New York</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Kim, Chun K" sort="Kim, Chun K" uniqKey="Kim C" first="Chun K" last="Kim">Chun K. Kim</name>
<affiliation wicri:level="1">
<nlm:aff id="I1">Department of Radiology, Division of Nuclear Medicine, The Mount Sinai School of Medicine, The Mount Sinai Hospital, New York, New York, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Radiology, Division of Nuclear Medicine, The Mount Sinai School of Medicine, The Mount Sinai Hospital, New York, New York</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PMC</idno>
<idno type="pmid">16277655</idno>
<idno type="pmc">1308847</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1308847</idno>
<idno type="RBID">PMC:1308847</idno>
<idno type="doi">10.1186/1477-7800-2-25</idno>
<date when="2005">2005</date>
<idno type="wicri:Area/Pmc/Corpus">001D08</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">001D08</idno>
<idno type="wicri:Area/Pmc/Curation">001D07</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">001D07</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a" type="main">Lymphoscintigraphy and triangulated body marking for morbidity reduction during sentinel node biopsy in breast cancer</title>
<author>
<name sortKey="Krynyckyi, Borys R" sort="Krynyckyi, Borys R" uniqKey="Krynyckyi B" first="Borys R" last="Krynyckyi">Borys R. Krynyckyi</name>
<affiliation wicri:level="1">
<nlm:aff id="I1">Department of Radiology, Division of Nuclear Medicine, The Mount Sinai School of Medicine, The Mount Sinai Hospital, New York, New York, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Radiology, Division of Nuclear Medicine, The Mount Sinai School of Medicine, The Mount Sinai Hospital, New York, New York</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Shafir, Michail K" sort="Shafir, Michail K" uniqKey="Shafir M" first="Michail K" last="Shafir">Michail K. Shafir</name>
<affiliation wicri:level="1">
<nlm:aff id="I2">Department of Surgery, The Mount Sinai School of Medicine, The Mount Sinai Hospital, New York, New York, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Surgery, The Mount Sinai School of Medicine, The Mount Sinai Hospital, New York, New York</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Kim, Suk Chul" sort="Kim, Suk Chul" uniqKey="Kim S" first="Suk Chul" last="Kim">Suk Chul Kim</name>
<affiliation wicri:level="1">
<nlm:aff id="I1">Department of Radiology, Division of Nuclear Medicine, The Mount Sinai School of Medicine, The Mount Sinai Hospital, New York, New York, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Radiology, Division of Nuclear Medicine, The Mount Sinai School of Medicine, The Mount Sinai Hospital, New York, New York</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Kim, Dong Wook" sort="Kim, Dong Wook" uniqKey="Kim D" first="Dong Wook" last="Kim">Dong Wook Kim</name>
<affiliation wicri:level="1">
<nlm:aff id="I1">Department of Radiology, Division of Nuclear Medicine, The Mount Sinai School of Medicine, The Mount Sinai Hospital, New York, New York, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Radiology, Division of Nuclear Medicine, The Mount Sinai School of Medicine, The Mount Sinai Hospital, New York, New York</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Travis, Arlene" sort="Travis, Arlene" uniqKey="Travis A" first="Arlene" last="Travis">Arlene Travis</name>
<affiliation wicri:level="1">
<nlm:aff id="I1">Department of Radiology, Division of Nuclear Medicine, The Mount Sinai School of Medicine, The Mount Sinai Hospital, New York, New York, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Radiology, Division of Nuclear Medicine, The Mount Sinai School of Medicine, The Mount Sinai Hospital, New York, New York</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Moadel, Renee M" sort="Moadel, Renee M" uniqKey="Moadel R" first="Renee M" last="Moadel">Renee M. Moadel</name>
<affiliation wicri:level="1">
<nlm:aff id="I3">Department of Nuclear Medicine, Albert Einstein College of Medicine of Yeshiva University, and the Montefiore Medical Center, Bronx, New York, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Nuclear Medicine, Albert Einstein College of Medicine of Yeshiva University, and the Montefiore Medical Center, Bronx, New York</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Kim, Chun K" sort="Kim, Chun K" uniqKey="Kim C" first="Chun K" last="Kim">Chun K. Kim</name>
<affiliation wicri:level="1">
<nlm:aff id="I1">Department of Radiology, Division of Nuclear Medicine, The Mount Sinai School of Medicine, The Mount Sinai Hospital, New York, New York, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Radiology, Division of Nuclear Medicine, The Mount Sinai School of Medicine, The Mount Sinai Hospital, New York, New York</wicri:regionArea>
</affiliation>
</author>
</analytic>
<series>
<title level="j">International seminars in surgical oncology : ISSO</title>
<idno type="eISSN">1477-7800</idno>
<imprint>
<date when="2005">2005</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p>Current trends in patient care include the desire for minimizing invasiveness of procedures and interventions. This aim is reflected in the increasing utilization of sentinel lymph node biopsy, which results in a lower level of morbidity in breast cancer staging, in comparison to extensive conventional axillary dissection. Optimized lymphoscintigraphy with triangulated body marking is a clinical option that can further reduce morbidity, more than when a hand held gamma probe alone is utilized. Unfortunately it is often either overlooked or not fully understood, and thus not utilized. This results in the unnecessary loss of an opportunity to further reduce morbidity.</p>
<p>Optimized lymphoscintigraphy and triangulated body marking provides a detailed 3 dimensional map of the number and location of the sentinel nodes, available before the first incision is made. The number, location, relevance based on time/sequence of appearance of the nodes, all can influence 1) where the incision is made, 2) how extensive the dissection is, and 3) how many nodes are removed. In addition, complex patterns can arise from injections. These include prominent lymphatic channels, pseudo-sentinel nodes, echelon and reverse echelon nodes and even contamination, which are much more difficult to access with the probe only. With the detailed information provided by optimized lymphoscintigraphy and triangulated body marking, the surgeon can approach the axilla in a more enlightened fashion, in contrast to when the less informed probe only method is used. This allows for better planning, resulting in the best cosmetic effect and less trauma to the tissues, further reducing morbidity while maintaining adequate sampling of the sentinel node(s).</p>
</div>
</front>
<back>
<div1 type="bibliography">
<listBibl>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
</listBibl>
</div1>
</back>
</TEI>
<pmc article-type="review-article">
<pmc-dir>properties open_access</pmc-dir>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Int Semin Surg Oncol</journal-id>
<journal-title>International seminars in surgical oncology : ISSO</journal-title>
<issn pub-type="epub">1477-7800</issn>
<publisher>
<publisher-name>BioMed Central</publisher-name>
<publisher-loc>London</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">16277655</article-id>
<article-id pub-id-type="pmc">1308847</article-id>
<article-id pub-id-type="publisher-id">1477-7800-2-25</article-id>
<article-id pub-id-type="doi">10.1186/1477-7800-2-25</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Lymphoscintigraphy and triangulated body marking for morbidity reduction during sentinel node biopsy in breast cancer</article-title>
</title-group>
<contrib-group>
<contrib id="A1" corresp="yes" contrib-type="author">
<name>
<surname>Krynyckyi</surname>
<given-names>Borys R</given-names>
</name>
<xref ref-type="aff" rid="I1">1</xref>
<email>syrob@msn.com</email>
</contrib>
<contrib id="A2" contrib-type="author">
<name>
<surname>Shafir</surname>
<given-names>Michail K</given-names>
</name>
<xref ref-type="aff" rid="I2">2</xref>
<email>michail.shafir@msnyuhealth.org</email>
</contrib>
<contrib id="A3" contrib-type="author">
<name>
<surname>Kim</surname>
<given-names>Suk Chul</given-names>
</name>
<xref ref-type="aff" rid="I1">1</xref>
<email>sukchulkim@gmail.com</email>
</contrib>
<contrib id="A4" contrib-type="author">
<name>
<surname>Kim</surname>
<given-names>Dong Wook</given-names>
</name>
<xref ref-type="aff" rid="I1">1</xref>
<email>mdwook@empas.com</email>
</contrib>
<contrib id="A5" contrib-type="author">
<name>
<surname>Travis</surname>
<given-names>Arlene</given-names>
</name>
<xref ref-type="aff" rid="I1">1</xref>
<email>arlene.travis@mssm.edu</email>
</contrib>
<contrib id="A6" contrib-type="author">
<name>
<surname>Moadel</surname>
<given-names>Renee M</given-names>
</name>
<xref ref-type="aff" rid="I3">3</xref>
<email>rmoadel@montefiore.org</email>
</contrib>
<contrib id="A7" contrib-type="author">
<name>
<surname>Kim</surname>
<given-names>Chun K</given-names>
</name>
<xref ref-type="aff" rid="I1">1</xref>
<email>chun.kim@msnyuhealth.org</email>
</contrib>
</contrib-group>
<aff id="I1">
<label>1</label>
Department of Radiology, Division of Nuclear Medicine, The Mount Sinai School of Medicine, The Mount Sinai Hospital, New York, New York, USA</aff>
<aff id="I2">
<label>2</label>
Department of Surgery, The Mount Sinai School of Medicine, The Mount Sinai Hospital, New York, New York, USA</aff>
<aff id="I3">
<label>3</label>
Department of Nuclear Medicine, Albert Einstein College of Medicine of Yeshiva University, and the Montefiore Medical Center, Bronx, New York, USA</aff>
<pub-date pub-type="collection">
<year>2005</year>
</pub-date>
<pub-date pub-type="epub">
<day>8</day>
<month>11</month>
<year>2005</year>
</pub-date>
<volume>2</volume>
<fpage>25</fpage>
<lpage>25</lpage>
<ext-link ext-link-type="uri" xlink:href="http://www.issoonline.com/content/2/1/25"></ext-link>
<history>
<date date-type="received">
<day>12</day>
<month>10</month>
<year>2005</year>
</date>
<date date-type="accepted">
<day>8</day>
<month>11</month>
<year>2005</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2005 Krynyckyi et al; licensee BioMed Central Ltd.</copyright-statement>
<copyright-year>2005</copyright-year>
<copyright-holder>Krynyckyi et al; licensee BioMed Central Ltd.</copyright-holder>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0">
<p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (
<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"></ext-link>
), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p>
<pmc-comment> Krynyckyi R Borys syrob@msn.com Lymphoscintigraphy and triangulated body marking for morbidity reduction during sentinel node biopsy in breast cancer 2005International Seminars in Surgical Oncology 2(1): 25-. (2005)1477-7800(2005)2:1<25>urn:ISSN:1477-7800</pmc-comment>
</license>
</permissions>
<abstract>
<p>Current trends in patient care include the desire for minimizing invasiveness of procedures and interventions. This aim is reflected in the increasing utilization of sentinel lymph node biopsy, which results in a lower level of morbidity in breast cancer staging, in comparison to extensive conventional axillary dissection. Optimized lymphoscintigraphy with triangulated body marking is a clinical option that can further reduce morbidity, more than when a hand held gamma probe alone is utilized. Unfortunately it is often either overlooked or not fully understood, and thus not utilized. This results in the unnecessary loss of an opportunity to further reduce morbidity.</p>
<p>Optimized lymphoscintigraphy and triangulated body marking provides a detailed 3 dimensional map of the number and location of the sentinel nodes, available before the first incision is made. The number, location, relevance based on time/sequence of appearance of the nodes, all can influence 1) where the incision is made, 2) how extensive the dissection is, and 3) how many nodes are removed. In addition, complex patterns can arise from injections. These include prominent lymphatic channels, pseudo-sentinel nodes, echelon and reverse echelon nodes and even contamination, which are much more difficult to access with the probe only. With the detailed information provided by optimized lymphoscintigraphy and triangulated body marking, the surgeon can approach the axilla in a more enlightened fashion, in contrast to when the less informed probe only method is used. This allows for better planning, resulting in the best cosmetic effect and less trauma to the tissues, further reducing morbidity while maintaining adequate sampling of the sentinel node(s).</p>
</abstract>
</article-meta>
</front>
</pmc>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Pmc/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001D07 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Pmc/Curation/biblio.hfd -nk 001D07 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Pmc
   |étape=   Curation
   |type=    RBID
   |clé=     PMC:1308847
   |texte=   Lymphoscintigraphy and triangulated body marking for morbidity reduction during sentinel node biopsy in breast cancer
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Curation/RBID.i   -Sk "pubmed:16277655" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1 

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024